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Summary. Policy decisions often require synthesis of evidence from multiple sources, and the
source studies typically vary in rigour and in relevance to the target question.We present simple
methods of allowing for differences in rigour (or lack of internal bias) and relevance (or lack of
external bias) in evidence synthesis. The methods are developed in the context of reanalysing
a UK National Institute for Clinical Excellence technology appraisal in antenatal care, which
includes eight comparative studies. Many were historically controlled, only one was a random-
ized trial and doses, populations and outcomes varied between studies and differed from the
target UK setting. Using elicited opinion, we construct prior distributions to represent the biases
in each study and perform a bias-adjusted meta-analysis. Adjustment had the effect of shifting
the combined estimate away from the null by approximately 10%, and the variance of the com-
bined estimate was almost tripled. Our generic bias modelling approach allows decisions to be
based on all available evidence, with less rigorous or less relevant studies downweighted by
using computationally simple methods.
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1. Introduction
Standard methods for meta-analysis assume that all studies have addressed the same question in
a similar way and therefore provide information on common parameters of interest. In practice,
however, the studies vary in degree of rigour and in relevance to the research question. Rigour
(or lack of internal bias) reﬂects how well a study estimates its intended parameters and varies
according to use of randomization, adequacy of allocation concealment, degree of blinding
and attrition levels. Relevance (or lack of external bias) is deﬁned with respect to a target ques-
tion. For example, in a typical comparison of two interventions, the objective is to compare
the effect of the interventions on a speciﬁed primary outcome in a particular population. The
source studies that are available may differ from this target setting, with respect to study popu-
lation, outcomes measured and details of interventions. This paper is motivated primarily by
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meta-analyses that were carried out to inform policy decisions, where a target question is pre-
deﬁned, but varying relevance also affects the interpretation of any meta-analysis.
Differences in rigour and relevance between studies which are potentially eligible in a sys-
tematic review are typically addressed by choosing a minimum threshold for inclusion. This
introduces an arbitrary division and valuable evidencemay be discarded (Gluud, 2006). Of addi-
tional concern is a failure to adjust for the remaining internal and external biases in the studies
selected. The majority of systematic reviews assess the methodological quality of their source
studies (de Craen et al., 2005), but only about 50% make use of the quality assessment and this is
usually only through sensitivity analyses or exploratory subgroup analyses (Moja et al., 2005).
In general, the primary analysis of the review makes no allowance for differences in rigour and
relevance. Consequently, biases in the studies included are incorporated in the overall results.
If a bias affecting a particular study were of known magnitude, bias adjustment could be
achieved simply by shifting the study effect estimate and interval. Typically, however, the inter-
nal and external biases are of unknownmagnitude, and this uncertainty shouldbe acknowledged
in the analysis, resulting in a wider interval as well as a shift of location. It is misleading to report
conﬁdence intervals (CIs) which reﬂect only the extent of possible random errorwhen systematic
biases are suspected (Greenland, 2005). The uncertainty which is due to systematic biases is,
unfortunately, more difﬁcult to quantify and cannot be evaluated by using statistical methods
alone. It has been recommended that scientiﬁc judgement is used to evaluate this uncertainty,
using all the relevant information that is available (Taylor and Kuyatt, 1994).
Several methods of adjusting for biases in meta-analysis have been proposed. Weighting the
analysis by quality scores is known to be inadequate (Greenland and O’Rourke, 2001); among
other reasons, many quality items contributing to the score may have no association with bias,
and there is no allowance for the direction of biases. Spiegelhalter and Best (2003) acknowl-
edged potential biases in a set of studies by assuming an additive bias in the effect of interest
(treatment effect, for example). Distributions that are chosen directly for parameters represent-
ing the internal and external bias in each study inﬂuence the relative weighting of studies in the
pooled analysis. Other researchers have adjusted for multiple sources of bias by using a model-
based approach: distributions are speciﬁed for a set of parameters which together determine
the bias in the target effect, and separate parametric models are used for each speciﬁc source of
bias. Eddy et al. (1992), in their conﬁdence proﬁle method for meta-analysis, presented models
for multiple internal and external biases and incorporated these into the likelihood to obtain
bias-adjusted results. Wolpert and Mengersen (2004) similarly used a full likelihood approach
to adjust for biases due to eligibility violation, and misclassiﬁcation of exposure or outcome.
Greenland (2005) constructed separate models for the bias due to uncontrolled confounding,
non-response and misclassiﬁcation of exposure and used Monte Carlo simulation methods and
approximate adjustments to sample and adjust for the individual biases, rather than taking a
full likelihood approach.
Our objective in this paper is to provide simple generic methods for allowing for internal
and external biases in meta-analysis and evidence synthesis. The term ‘evidence synthesis’ refers
to a broader class of analyses, encompassing synthesis of results from diverse sources, e.g.
different study designs, different treatment comparisons and different clinical end points (Ades
and Sutton, 2006). Our approach to bias adjustment is intermediate in complexity between
the multiple-bias modelling approaches that were discussed above and the simpler approach
that was taken by Spiegelhalter and Best. We model biases due to individual sources, as did
Eddy et al. (1992), Wolpert and Mengersen (2004) and Greenland (2005), but assume a direct
form for the bias in the target parameter, as did Spiegelhalter and Best (2003). Estimation of
bias-adjusted results is achieved by using moment-based methods, and we provide tools for
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elicitation of distributions for the biases in a set of studies. We aim to present methods which
are accessible in a routine analysis setting.
We develop our methods in the context of an example in antenatal care, which concerns the
effectiveness of routine anti-D prophylaxis in pregnant women who are Rhesus negative. The
purpose of anti-D prophylaxis is to prevent ‘sensitization’ of the mother, to avoid haemolyt-
ic disease of the newborn in subsequent pregnancies. A technology appraisal (Chilcott et al.,
2003) that was commissioned by the UK National Institute for Clinical Excellence (NICE)
identiﬁed 11 relevant studies, which were subject to many internal and external biases. Many of
the studies were historically controlled, only one was a randomized trial and doses, populations
and outcomes varied between studies and differed from the target UK setting. The principal
conclusions in the NICE appraisal were based on meta-analysis of the two studies that were
considered most relevant, which were selected according to dose and population type.
The outline of this paper is as follows. Section 2 discusses identiﬁcation of internal and exter-
nal biases. In Section 3, we present our approach to adjustment for biases whichmay be assumed
to act additively on the intervention effect, and in Section 4 our tools for quantifying bias. Sec-
tion 5 reports the application of these methods to the anti-D prophylaxis example. In Section 6,
we describe methods for adjusting for biases which depend on the magnitude of the intervention
effect. Section 7 discusses incorporation of empirical evidence on bias.
2. Identifying internal and external biases
To make allowance for internal and external biases in an evidence synthesis, we must ﬁrst iden-
tify all potential sources of bias in the set of selected studies. It is helpful to break this task down
into a series of smaller steps. The ﬁrst step is to write down a precise deﬁnition of the target
question, which should describe the population to whom the results of the evidence synthesis
will be generalized, details of the target comparison (e.g. intervention and control policies, in a
standard two-arm comparison) and the outcome of interest.
When identifying the biases that are present in a study, it is not trivial to distinguish external
from internal biases. For example, consider a study which recruited different populations in
the intervention and control arms, neither identical to the target population. It is clear that
differences between populations will cause both internal and external bias with respect to the
target question, but unclear how to determine the extent of each bias. To address this problem,
we ﬁrst envisage an idealized version of each source study and write down a miniprotocol for
it. The idealized study can be viewed as a repeat of the original study by using a design which
eliminates all sources of internal bias. In the miniprotocol, we specify the population which the
researchers planned to study, their planned comparison and the outcome which they planned
to measure. This information is usually easily extracted from the abstract and early sections of
the study publication. In the idealized study, the population recruited and the outcome mea-
sured would be identical in the intervention and control arms. It may be helpful to think of the
idealized study as a perfect randomized controlled trial, but note that this design need not be
practicable, for instance where ethical issues prevent use of randomization or blinding.
The process of identifying internal and external biases is now much simpler (Fig. 1). To
identify internal biases, we compare the details of the completed source study against the mini-
protocol for its idealized study. To identify external biases, we compare each idealized study
against the target question. An additional advantage of separating the two tasks is that they
can be undertaken independently by different members of the research team. For example, in
the medical ﬁeld, it may be desirable that internal biases are assessed by a group that is led by a
statistician or epidemiologist, and external biases by a group that is led by a clinician.
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Fig. 1. Identifying internal and external biases
To reiterate our approach proposed above, the steps are as follows.
(a) Deﬁne the target question.
(b) Write down a miniprotocol for an idealized version of each study.
(c) Identify internal biases by comparing the original study against the idealized study.
(d) Identify external biases by comparing the idealized study against the target question.
Tools for completion of steps (c) and (d) are provided in Section 4.
For bias modelling, we would like to group individual biases into broader categories of bias,
which may be assumed to be independent (see Fig. 1). For internal bias, we have chosen to use
the following categorization which has been used elsewhere (Higgins and Green, 2005; Deeks et
al., 2003): selection bias; performance bias; attrition bias; detection bias. Selection bias refers to
systematic differences between comparison groups at baseline. Performance bias represents sys-
tematic differences other than the study comparison; this may be caused by inadequate blinding
of participants in trials and by misclassiﬁcation of exposure in observational studies. Attrition
bias reﬂects systematic differences between comparison groups in exclusions and drop-outs.
Detection bias describes systematic differences between groups in outcome assessment, which
may result from a lack of standardization and blinding of those assessing the outcome. We have
added a further internal bias category, ‘other bias suspected’, to represent the opinion that addi-
tional biases seem likely. For example, this would cover suspicion that there are inconsistencies
in a published study which suggest erroneous results.
For external bias, the bias categories represent the differences between the idealized studies
and the four components of the target question: population bias; intervention bias; control bias;
outcome bias. For example, population bias may reﬂect differences in age, sex or health status of
the idealized study participants, compared with the target population. Intervention bias refers
to differences in dose, timing or delivery method of the idealized study intervention compared
with the target intervention, and similarly control bias refers to differences in the control strat-
egy. When the target question is a comparison of two active interventions, intervention bias and
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control bias would be relabelled appropriately. Outcome bias may represent differences in the
deﬁnition, timing or method of measurement of the idealized study outcome compared with
the target.
There may be some ﬂexibility over how to deﬁne the idealized study, e.g. where a study has
measured several outcomes and none is identical to the target outcome. The aim is to maximize
the information that is supplied by the study with respect to the target question and this could
mean weighing up relevance against the extent of missing data. We do not here address publica-
tion bias or selective reporting of outcomes, for which methods have been discussed elsewhere
(Rothstein et al., 2005;Williamson andGamble, 2005). These issues should be confronted before
considering potential biases within the data set that is available.
3. Simple approach to bias adjustment
In this section, we propose a simple method of adjusting for internal and external biases in
meta-analysis. We wish to estimate some underlying quantity θ, which is the ‘true’ intervention
effect in our target setting. For a two-arm comparison, θ represents the difference in the target
end point between the target intervention and control policies, when assessed within the target
population. The intervention effect is deﬁned on a scale on which it is reasonable to assume that
most biases act additively.
Suppose that there are k studies, i=1, . . . , k, and each provides a statistic yi (with sampling
variance s2i assumed known) as a conventional estimator of some underlying study-speciﬁc
quantity θi, which is the true intervention effect according to the idealized protocol for study
i. We assume that, if there were no internal biases, then for each study yi ∼f.θi, s2i /, where the
notation f.μ,σ2/ represents a general distribution with mean μ and variance σ2. We assume
also that, if there were no external biases, all the studies would be measuring the target quan-
tity so θi = θ. Thus internal biases reﬂect that the above sampling distribution is not a correct
assumption, whereas external biases reﬂect that θi is not equal to θ. All the development below
carries through by using moments and does not require assumptions of normality.
The method of adjustment that is proposed here is appropriate only for biases which may
be regarded as independent of the magnitude of the intervention effect, and we refer to these
as additive biases. Examples are given in Section 4.1, and in Section 6 we discuss methods of
adjusting for biases which are proportional to the intervention effect.
3.1. Incorporating internal biases
We use superscripts I and E to distinguish internal and external biases. For multiple indepen-
dent sources j = 1, . . . ,J I of internal bias, we write δIij to denote the effect of bias source j on
the estimated intervention effect in study i. δIij is unknown, and we assume that our uncertainty
about δIij is represented by a distribution δ
I
ij ∼f.μIij,σI 2ij /. Methods for elicitation of μIij and σI 2ij
are presented in Section 4. Having elicited μIij and σ
I 2
ij , assuming independence between sources
of bias means that the total internal bias in the ith study is δIi ∼ f.μIi ,σI 2i /, where μIi =Σj μIij
and σI 2i =Σj σI 2ij .
To allow for internal biases, we assume an additive bias model yi|δIi ∼f.θi + δIi , s2i /, or equiv-
alently
yi ∼f.θi +μIi , s2i +σI 2i / .1/
or equivalently yi −μIi ∼f.θi, s2i =αi/, where αi = s2i =.s2i +σI 2i /. αi can be interpreted as a quality
weight for rigour, representing the proportion of within-study variability that is unrelated to
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internal biases (Spiegelhalter and Best, 2003). Highly rigorous studies would have αi near to
1, whereas less rigorous studies would have lower αi and would thus be downweighted in the
meta-analysis.
3.2. Incorporating external biases
We assume multiple independent sources j =1, . . . ,JE of external bias and write δEij to denote
the effect of bias source j in study i. As for the internal biases, a distribution δEij ∼f.μEij,σE 2ij / is
assumed for each bias in each study. We include an additional variance parameter τ2 to repre-
sent unexplained between-study heterogeneity. If adjusting perfectly for internal and external
biases, there would be no remaining heterogeneity, so the estimate of τ2 provides a gauge of
our success in addressing the biases. Having elicited μEij and σ
E 2
ij , the total external bias in the
ith study is δEi ∼f.μEi ,σE 2i /, where μEi =Σj μEij and σE 2i =Σj σE 2ij . Then the external bias model
may be written as
θi ∼f.θ+μEi , τ2 +σE 2i /:
Wenote that this is not a standard random-effectsmodel formeta-analysis, whichwould assume
that all θi are ‘exchangeable’, i.e. have the same distribution.
Thus, assuming no internal biases, we have yi|δEi ∼f.θ+ δEi , s2i /, or equivalently
yi ∼f.θ+μEi , s2i + τ2 +σE 2i /, .2/
or equivalently, when τ2 is non-zero, yi −μEi ∼f.θ, s2i + τ2=γi/, where γi = τ2=.τ2 +σE 2i / can
be interpreted as a relevance weight, representing the proportion of between-study variability
that is unrelated to external biases (Spiegelhalter and Best, 2003). Idealized studies which are
highly relevant to the target setting would have γi near to 1, whereas less relevant studies with
lower γi would be downweighted in the random-effects analysis.
3.3. Adjusting for both internal and external biases
By combining the earlier models (1) and (2), we obtain a model which incorporates internal and
external biases,
yi ∼f.θ+μIi +μEi , s2i +σI 2i + τ2 +σE 2i /, .3/
or equivalently yi −μIi −μEi ∼f.θ, s2i =αi + τ2=γi/. This can be interpreted as a random-effects
meta-analysis formulation, in which the location is adjusted for systematic biases, and within-
and between-study variability are multiplied by quality weights for rigour and relevance respec-
tively.
The inverse variance estimator of θ is
θˆ=
∑
i
yi −μIi −μEi
s2i =αi + τˆ2=γi∑
i
.s2i =αi + τˆ2=γi/−1
with approximate standard error
SE.θˆ/=
√⎧⎪⎨
⎪⎩
1∑
i
.s2i =αi + τˆ2=γi/−1
⎫⎪⎬
⎪⎭:
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Assuming approximate normality for the estimator θˆ, a 95% CI for θ is .θˆ −1:96 SE.θˆ/, θˆ +
1:96 SE.θˆ//. This assumption is based on a central limit theorem argument, noting again that
we do not require normality in the individual bias distributions.
To perform these calculations, an estimate for τ2 is required and it is convenient to use a
method-of-moments estimate that is based on the heterogeneity statistic Q (DerSimonian and
Laird, 1986). Here, this is derived from a ﬁxed effect estimate which allows for internal and
external biases, θˆF =Σiwi.yi −μIi −μEi /=Σiwi, where wi = .s2i +σI 2i +σE 2i /−1. The heterogen-
eity statistic is given by Q=Σiwi.yi −μIi −μEi − θˆF/2 and a moment estimate for τ2 is
τˆ2 = Q− .k −1/∑
i
wi −
∑
i
w2i =
∑
i
wi
: .4/
The estimate is set to 0 if τˆ2 is negative. In the setting of meta-analysis, negative values would
represent greater variation within than between studies, which is not considered plausible. The
relevance weights γi are now calculated by using the estimate τˆ2.
4. Quantifying bias
To adjust for internal and external biases by using themoment-basedmethod that was presented
in Section 3, we require distributions for each bias in each study. These would ideally be based
on empirical evidence. However, although some empirical studies of bias have been published,
these report estimates and CIs for average bias only and do not provide measures of between-
study variation in bias. We return to this and give a brief review of the relevant literature in
Section 7. In the absence of empirical evidence, we propose a two-stage approach for construct-
ing the required bias distributions from elicited opinion. First, checklists are used to extract
qualitative details of study characteristics which could potentially cause bias, for each of the
ﬁve internal and four external bias categories. Next, distributions for each bias are quantiﬁed,
through marking estimated ranges on elicitation scales.
4.1. Checklists for bias
The items that are included in the checklists for sources of internal and external bias (Tables 1
and 2) are based on theDowns andBlack (1998) checklist for assessing themethodological qual-
ity of randomized and non-randomized studies. The checklists are completed with reference to
the original study publications, the target question and miniprotocols for idealized versions
of each study (as discussed in Section 2). To complete the checklist for internal bias (Table 1),
we compare the details that are provided by the study publication against the idealized study.
Answers should be given with regard to the results for the chosen idealized outcome, since
potential for bias may vary between outcomes within a study. Study features which led to each
answer are described brieﬂy in the ‘Description’ column of Table 1.
The bias checklist includes a judgement of whether each bias depends on the magnitude of
the intervention effect. We treat biases which do not as ‘additive’ biases, and biases which do
as ‘proportional’ biases, and our elicitation process and model for adjustment differ according
to type. For example, the external bias that is caused by a study’s dose differing from the target
dose of treatment is proportional to the intervention effect, whereas the internal bias that is
caused by recruiting two study groups from different populations is independent of the inter-
vention effect. Proportional biases are addressed in Section 6. The assumption that all biases
can be categorized as either additive or proportional is a simpliﬁcation, which we return to in
Section 8.
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Table 1. Checklist for sources of internal bias†
Question Yes/no/ Description
unclear
Selection bias
Subjects in different intervention groups recruited from same populations?
Subjects in different intervention groups recruited over same time periods?
Inclusion and exclusion criteria clear?
Randomization used?
Adequate allocation concealment?
Comparable baseline characteristics?
Adequate adjustment for confounding? [In observational studies only]
Does extent of selection bias depend on magnitude of intervention effect?
Performance bias
Subjects blinded?
Care givers blinded?
Did subjects receive their assigned (or reputedly received) interventions?
Does extent of performance bias depend on magnitude of intervention effect?
Attrition bias
Are the results unlikely to be affected by losses to follow-up?
Are the results unlikely to be affected by post hoc exclusions?
Does extent of attrition bias depend on magnitude of intervention effect?
Detection bias
Outcome assessors blinded?
Outcome measured accurately?
If the results were back-calculated from a reported analysis, was the
statistical analysis appropriate?
Does extent of detection bias depend on magnitude of intervention effect?
Other bias suspected
Does extent of other bias depend on magnitude of intervention effect?
†The empty areas are to be completed.
To complete the checklist for external bias (Table 2), we compare the details of each idealized
study against the target question. As in Table 1, a description of relevant study characteristics
is recorded alongside the answer to each question and the checklist includes a judgement of
whether each bias depends on the intervention effect. With an adequate ‘idealized protocol’,
assessment of external biases does not require access to the original study publication and could
(or even should) therefore be carried out without knowledge of the study results. It is also desir-
able that internal biases are assessed blind, but the practicalities are more difﬁcult. In principle,
the results in the study publications could be concealed by a third party so that internal biases are
assessed without knowledge of the study results. However, this does not overcome the problem
that assessors who work in a closely related ﬁeld may already know the study results. Assessors
should certainly not base their opinions concerning size of additive biases on the magnitude of
observed effect or sampling variance, since this would violate the assumption of independence
between the additive biases and the effect estimate yi.
4.2. Elicitation scales
The completed bias checklists (Tables 1 and 2) are used to inform an opinion on the size of each
bias affecting each study. In this section, we discuss elicitation for all additive biases that are
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Table 2. Checklist for sources of external bias†
Question Yes/no/unclear Description
Population bias
Study subjects in idealized study drawn
from population identical to target
population, with respect to age, sex, health
status etc.?
Does extent of population bias depend on
magnitude of intervention effect?
Intervention bias
Active intervention in idealized study
identical to target active intervention in
dose, timing etc.?
Does extent of intervention bias depend on
magnitude of intervention effect?
Control bias
Control intervention in idealized study
identical to target control intervention?
Does extent of control bias depend on
magnitude of intervention effect?
Outcome bias
Study outcome for idealized study identical
to target outcome?
Does extent of outcome bias depend on
magnitude of intervention effect?
†The empty areas are to be completed.
identiﬁed in Tables 1 and 2, which do not depend on the magnitude of the intervention effect.
We return to proportional biases in Section 6. Below we consider elicitation of the biases affect-
ing relative risk, but the methods could be easily modiﬁed for other measures of intervention
effect.
Ideally, several assessors would be asked to provide their opinion on the size of each bias
in every study. For each internal bias category, the assessor is asked to consider the following
question, taking into account the information that is extracted in Table 1.
Even if there were no intervention effect in this study, what apparent effect (ignoring sampling
variation) might be induced by this bias?
The assessor is given a copy of an elicitation scale (Fig. 2) for each bias and asked to mark
a 67% range for the relative risk of the adverse outcome chosen in that study such that they
feel that the true answer to the question is twice as likely to lie inside rather than outside this
range. Our decision to elicit an interval corresponding to moderate rather than high probability
Risk lower in intervention group 
(or higher in control group) 
Risk lower in control group 
(or higher in intervention group) 
.1 .2 .3 .4 .5 .5 .4 .3 .2 .1.6 .6.7 .7.8 .8.9 .91
Fig. 2. Elicitation scale for quantifying additive bias
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Fig. 3. Effect of ranges for bias on the approximate width of the CI for the bias-adjusted log-odds-ratio,
assuming rare events and no intervention effect (ranges refer to a symmetric relative risk scale, as shown in
Fig. 2): , no bias; – – –, 67% range (0.9, 0.9); . . . . . . ., 67% range (0.7, 0.7); -  -  - , 67% range (0.5,
0.5)
is based on ﬁndings that peoples’ performance at assessing intervals tends to be better for lower
levels of certainty (O’Hagan et al., 2006).
The relative risk scale that is shown is symmetric with respect to the study arms, so a doubling
of risk in the control group compared with the intervention group is marked as 0.5 on the left-
hand half of the scale, whereas a doubling of risk in the intervention group is marked as 0.5 on
the right-hand half. Range limits marked symmetrically around 1 represent a belief that the bias
is equally likely to be in favour of the control as in favour of the intervention. Relative risk values
are marked on a log-scale, since this will be used when constructing probability distributions.
To ease the process of choosing numerical limits for each bias, we recommend that assessors
ﬁrst make a qualitative judgement of the severity of bias, before quantifying their opinion as a
67% range. Assessors write down their judgement of the severity of bias (as none, low, medium
or high) in favour of the intervention and, separately, the severity of bias in favour of the con-
trol. We suggest the following correspondence between qualitative judgements of severity and
choices for the range limit: none (1); low (0.9–1); medium (0.7–0.9); high (less than 0.7). These
divisions are guided by consideration of the effect of different ranges of bias on the CI for a log-
odds-ratio (Fig. 3). For convenience, we assume that events are rare and that the intervention
has no effect. In a trial which observes 10 events per arm, adjustment for a bias with 67% range
(0.9, 0.9) has little effect; the standard error for the log-odds-ratio is increased by only 2.7%,
which is equivalent to reducing the number of observed events to 9.5 per arm. Adjustment for
a bias with a wider range of (0.7, 0.7) or (0.5, 0.5) causes the standard error to increase by 28%
or 84% respectively, which is equivalent to reducing the number of events to 6.1 or 2.9 per arm.
For each external bias category, the assessor is asked to consider the following question,
taking into account the information that is extracted in Table 2.
Even if there were no effect in a study addressing the target question, what effect might there
be in an idealized version of the present study (i.e. assuming no internal biases)?
For each external bias in every study, the assessor is asked to mark a 67% range on an elicitation
scale (Fig. 2), as described above for internal bias.
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To construct a probability distribution from the range estimate that is chosen for each bias,
we work on the log-scale. For bias j in study i, the range limits aij on the left-hand half of the
elicitation scale and bij on the right-hand half correspond to range limits log.aij/, log.1=bij/
on a scale representing the log-relative-risk for intervention compared with control. For con-
venience, we assume that the 67% range represents approximately μij ±σij, as it would under
normality, and obtain the following elicited values for μij and σij:
μij = log.aij/+ log.1=bij/2 ,
σij = log.1=bij/− log.aij/2 :
In this way, parameters μij and σ2ij that are required for application of the methods that were
proposed in Section 3 are elicited from each assessor for all categories of additive bias in
every study. The bias checklists and elicitation scales that are used may be obtained from a
technical report that is available on line at http://www.mrc-bsu.cam.ac.uk/BSUsite/
publications.
5. Example
5.1. Effectiveness of routine anti-D prophylaxis
Our example concerns the antenatal care of women who are Rhesus negative, i.e. women who
have no D antigen on their red blood cells. When a Rhesus negative woman is pregnant with a
Rhesus positive fetus, there is a danger of ‘sensitization’, where contact between fetal blood and
maternal blood causes the mother to produce antibodies to the D antigens in the fetal red blood
cells (Contreras, 1998). In any future pregnancies with a Rhesus positive fetus, these antibod-
ies may cross the placenta and lead to a condition that is known as haemolytic disease of the
newborn, which can in severe cases result in stillbirth, disability or neonatal death. Under the
preventative policy that was introduced in many countries in 1969, Rhesus negative mothers are
offered a dose of a blood product called anti-D immunoglobulin after birth of a Rhesus positive
baby. Women are also offered anti-D immunoglobulin after miscarriage or abortion, and over
time this has been extended to include other potentially sensitizing events such as amniocentesis
(which is an invasive procedure in which a sample of the amniotic ﬂuid surrounding the fetus is
extracted for testing) and occurrences of vaginal bleeding. Under this policy, the frequency of
haemolytic disease of the newborn is dramatically reduced, but cases still occur in about 1 in
21000 births. In 2001, the NICE in the UK commissioned an evaluation of the clinical effective-
ness and cost effectiveness of additionally offering routine antenatal anti-D immunoglobulin to
all unsensitized Rhesus negative women.
The NICE technology appraisal (Chilcott et al., 2003) identiﬁed 11 relevant studies. Since the
methodological quality of thesewas generally poor, the study results were potentially affected by
many internal biases. In addition, the dose of anti-D immunoglobulin that was used, the obstet-
ric history of the women who were studied and the timing of outcome measurement varied
between studies and often differed from the target UK setting, causing multiple external biases.
Owing to these problems, the ﬁnal NICE guidance was based principally on a meta-analysis of
only the two studies that were considered most relevant (Mayne et al., 1997; MacKenzie et al.,
1999), both of which evaluated the effectiveness of offering the target dose of anti-D immuno-
globulin to primigravidae (women who are pregnant for the ﬁrst time) in the UK. This analysis
provided strong evidence in favour of routine antenatal injection of anti-D immunoglobulin,
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with the odds ratio of sensitization estimated as 0.37 (95% CI 0.21, 0.65). The policy proposed
was also considered to be cost effective and, in 2002, the NICE recommended that it should be
implemented across the UK.
5.2. Quantifying biases in the anti-D immunoglobulin studies
We would like to quantify the internal and external biases in the anti-D immunoglobulin stud-
ies, to perform a bias-adjusted meta-analysis. This would address the concerns over internal
biases and varying relevance, while avoiding the need for rather arbitrary selection of studies.
We begin by using the tools that were presented in Section 4 to elicit probability distributions for
all additive biases. For convenience and for comparability with the NICE appraisal results, we
estimate the study treatment effects on the log-odds-ratio scale. The odds ratio may be assumed
to approximate the relative risk since the outcome is rare.
The advantages of eliciting judgements from several assessors rather than a single assessor
are clear, and we weighed up the beneﬁts of
(a) individual elicitation followed by mathematical pooling versus
(b) group elicitation, where a single consensus distribution is reached through discussion.
Our chosen elicitation process draws on both approaches.
(i) One assessor completes checklists for sources of bias (Tables 1 and 2).
(ii) All assessors read the original papers alongside the bias checklists and meet to discuss
queries and to reach a consensus on completed checklists.
(iii) Each assessormarks ranges on elicitation scales (Fig. 2), independently of other assessors.
(iv) Distributions from different assessors are pooled mathematically.
In this way, we hope to gain the advantages of group elicitation, knowledge sharing and resolu-
tion of misunderstandings, without the disadvantage that one individual could overly inﬂuence
the choice of consensus distribution (O’Hagan et al., 2006). As an additional safeguard against
simple errors, assessors are given feedback on exceptional instances of extremely divergent
opinion and are allowed to correct their opinion if a mistake has been made.
To demonstrate the methods, we discuss in detail the additive biases that were identiﬁed
in one of the anti-D immunoglobulin studies (Hermann et al., 1984), before proceeding to
a bias-adjusted meta-analysis. Hermann et al. (1984) reported sensitization status at 8 months
postpartum (after delivery) for two groups ofRhesus negativewomenwhowere delivered ofRhe-
sus positive babies in a Swedish hospital (Table 3). Women in the intervention group received
1250 international units (IUs) of anti-D immunoglobulin at about 32–34 weeks of gestation
during the period 1973–1977, and comparison was made against other women who had been
studied over the period 1968–1977 in earlier unpublished research. The target question for the
NICE appraisal of anti-D immunoglobulin is shown in Table 4, together with a miniprotocol
for an idealized version of Hermann et al. (1984), and we use these to identify the internal and
external biases as discussed in Section 2.
Using the bias checklists (Tables 1 and 2), we ﬁnd that amajor concern in this study is selection
bias: the controls were recruited in an earlier time period than women receiving the intervention,
no inclusion–exclusion criteria are presented for the control group and no attempt was made to
adjust for confounding. A lack of blinding means that performance bias is likely: subjects (or
care givers) may differ by group in willingness to report (or treat with anti-D immunoglobulin)
potentially sensitizing events such as bleeding. Attrition seems probable though not reported, in
that the available denominators represent the number of women who were delivered of Rhesus
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Table 4. Parameters of NICE target question and idealized version of Hermann et al. (1984)
Target question Idealized version of Hermann et al. (1984)
Population Unsensitized pregnant Rhesus Unsensitized Rhesus negative women
negative women in the UK delivered of Rhesus positive babies at
the Växjö hospital in Sweden
Intervention Dose of 500 IUs anti-D immunoglobulin Dose of 1250 IUs anti-D immunoglobulin
offered at 28 and 34 weeks’ gestation, in given at 32–34 weeks’ gestation, in
addition to control antenatal care addition to control antenatal care
Control Anti-D immunoglobulin offered Anti-D immunoglobulin offered
postpartum and after potentially postpartum and after potentially
sensitizing events during pregnancy sensitizing events during pregnancy
Outcome Rhesus sensitization which will affect a Rhesus sensitization at 8 months postpartum
subsequent pregnancy
positive babies, but the outcome is measured 8 months later. Additionally, there are post-base-
line exclusions from the intervention group. There are also minor issues over the lack of blinding
of outcome assessors (detection bias), a difference from the target population (population bias)
and a difference from the target control strategy (control bias). Biases related to dose and timing
of anti-D immunoglobulin are deferred to Section 6.
Fig. 4 shows the distributions that were elicited for additive biases in Hermann et al. (1984)
from four different assessors (the authors of this paper). Values on the left-hand side of the axis
represent bias which decreases the risk in the intervention group compared with the control
group, i.e. which would make the intervention appear more effective. Several of the biases in
Hermann et al. (1984) are expected to favour the intervention, though uncertainty is high and
many of the distributions that were elicited have a wide spread in both directions. The assessors’
opinions on the biases vary, but not dramatically so. All four distributions for total additive
bias are wide, with an expected value which favours the intervention.
The effect of adjusting the study results for total additive bias is illustrated in Fig. 5(a), for
the four assessors separately and pooled. We decided to pool across assessors after summing the
biases rather than before, because individuals may differently categorize potential sources of
bias. The pooled distribution for the bias-adjusted result is based on medians of the means and
standard deviations of the four assessors’ distributions for the bias-adjusted result. In principle,
we could choose to give more weight to certain assessors’ opinions on the basis of their greater
knowledge in particular areas, but selection of such weights would be difﬁcult in practice.
The effect of adjustment on the odds ratio and its 95% CI is not as great as might be expected
when looking at the bias distributions in Fig. 4, because the estimate from the Hermann et al.
(1984) study is fairly imprecise anyway (Table 5). The unadjusted odds ratio for sensitization,
comparing women receiving routine antenatal anti-D immunoglobulin against controls, is 0.24
(95% CI 0.05, 1.10). After allowance for additive biases under the assumptions of model (3), the
odds ratio is adjusted to 0.39 (95% CI 0.05, 3.04). The estimate has shifted towards 1 and, rather
than bordering on statistical signiﬁcance, the upper limit of the CI now extends well beyond the
null value.
To help those viewing the results to interpret the effect of bias adjustment, we convert the
odds ratio results into numbers of events that would be observed in each arm of a study of rare
events. Failure to allow for bias can be viewed as similar to overcounting rare events. In a large
study with similar sample sizes in each arm, the estimated log-odds-ratio θˆ and its variance
σˆ2 are approximately equal to log.r1=r0/ and r
−1
0 + r−11 respectively, where r0 and r1 represent
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Fig. 4. Additive biases in Hermann et al. (1984), 67% ranges of distributions elicited from four assessors
(A–D) and means and 67% ranges for total additive bias
the number of observed events in the control and treated arms. For a given θˆ and σˆ2, we can
therefore calculate the ‘effective number of events’ as {exp.θˆ/+1}= exp.θˆ/σˆ2 in the control arm
and {exp.θˆ/+1}=σˆ2 in the treated arm. In Hermann et al. (1984), adjustment for additive biases
is found to be analogous to removing more than half of the total effective number of events
(Table 5).
5.3. Bias-adjusted meta-analysis
Our original aim in the anti-D immunoglobulin example was to perform a bias-adjusted meta-
analysis of the 11 relevant studies that were identiﬁed by the NICE appraisal (Chilcott et al.,
2003). However, we have decided to exclude one study which made comparison with a published
control rate, for which no denominator was available (Parsons et al., 1998). In addition, three
of the 11 studies used the same group of control women. The second and third of these added in
results for women who had received the intervention since completion of the ﬁrst study, with-
out recruiting further controls (Bowman and Pollock, 1978, 1987). We consider only the ﬁrst
of these as a genuine comparative study (Bowman et al., 1978) and exclude the other two. The
example now comprises eight comparative studies of the effectiveness of routine antenatal injec-
tion of anti-D immunoglobulin in the prevention of sensitization of pregnant Rhesus negative
women (Bowman et al., 1978; Hermann et al., 1984; Huchet et al., 1987; Lee and Rawlinson,
1995; MacKenzie et al., 1999; Mayne et al., 1997; Tovey et al., 1983; Trolle, 1989). The observed
results are shown in Table 3, together with brief details of the study designs. In a conventional
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Bias adjusted (pooled)
Bias adjusted (D)
Bias adjusted (C)
Bias adjusted (B)
Bias adjusted (A)
Unadjusted
.01 .1 1 10 .01 .1 1 10
Odds ratio
(a) (b)
Fig. 5. Effect of adjusting for (a) additive bias and (b) all bias on the odds ratio (with 95% CIs) in Hermann
et al. (1984)
Table 5. Summary of results for Hermann et al. (1984) and for meta-analysis of eight anti-D immunoglobulin
studies, before and after adjusting for biases: estimated odds ratio of sensitization, comparing routine anti-D
immunoglobulin against control, and corresponding ‘effective number of events’ in each arm†
Bias adjustment Results for Hermann et al. (1984) analysis Results for meta-analysis
Odds ratio (95% CI) Effective number Odds ratio (95% CI) Effective number τˆ2
of events of events
Treated Control Treated Control
None 0.24 (0.05, 1.10) 2.1 8.5 0.28 (0.17, 0.46) 19.7 70.8 0.05
Additive biases 0.39 (0.05, 3.04) 1.3 3.3 0.29 (0.14, 0.57) 10.4 36.1 0
All biases 0.37 (0.03, 4.68) 0.8 2.2 0.25 (0.11, 0.56) 7.0 28.5 0
†Details are given in Section 5.2.
random-effects meta-analysis of these data, the odds ratio of sensitization, comparing routine
anti-D immunoglobulin treatment against control, is estimated as 0.28 (95% CI 0.17, 0.46). The
between-study variance for the log-odds-ratio is estimated as 0:222 =0:05.
As described for the Hermann et al. (1984) study in Section 5.2, we elicited distributions
for the additive biases in the other seven anti-D immunoglobulin studies. Under the assump-
tions of model (3), we adjust the study estimates and standard errors and perform a bias-
adjusted meta-analysis. The unadjusted and additive bias-adjusted study results are shown
in Figs 6(a) and 6(b), together with the unadjusted and additive bias-adjusted meta-analysis
results. The majority of the estimates have shifted towards the null value and the standard
errors for the intervention effect have increased for all studies. After adjustment for additive
bias, the total effective number of events that is represented by the results has fallen
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Fig. 6. Meta-analysis of eight studies evaluating the effectiveness of routine anti-D prophylaxis—unadjusted
and bias-adjusted odds ratios (with 95% CIs) (for each result, the corresponding total ‘effective number of
events’ is listed alongside): (a) unadjusted; (b) bias adjusted (additive); (c) bias adjusted (all)
substantially for most studies (Fig. 6). We note that the effective number of events represents
both the magnitude and the precision of the treatment effect. For example, the effective number
of events remains relatively high for Bowman et al. (1978), where the treatment effect is extreme,
though imprecisely estimated. The effect of bias adjustment is greater for more precise studies.
Among the anti-D immunoglobulin studies, the effect is most dramatic for MacKenzie et al.
(1999), which was the largest study and gave very precise results before adjustment for bias.
Here, the standard error almost doubles and the total effective number of events is quartered
after bias adjustment.
In a bias-adjusted meta-analysis, the odds ratio of sensitization is estimated as 0.29 (95% CI
0.14, 0.57), and the between-study variance τ2 is estimated as 0. There remains strong evidence
for the effectiveness of routine antenatal anti-D treatment, but the uncertainty has increased
(Table 5). The effect of bias adjustment on the overall odds ratio is analogous to halving the
total number of events in a large rare events study (Table 5).
Through adjusting for internal and external additive biases, we have reduced the estimated
heterogeneity to 0 and appear to have explained the systematic differences between the studies.
The reduction in heterogeneity is caused partly by a decrease in variability of the study estimates,
and partly by an increase in within-study uncertainty. After adjustment for additive biases, the
variance of the log-odds-ratio estimates has decreased by 27%, whereas a measure of the typical
within-study variance (Higgins and Thompson, 2002) has approximately doubled.
6. Adjusting for proportional biases
6.1. Models for adjustment
We now consider biases which depend on the magnitude of the intervention effect. Examples
include the external bias that is caused by a study delivering the intervention to only a subset of
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the target population, and the internal bias due to a study excluding non-compliers who did not
receive the intervention. The ﬁrst of these reduces the intervention effect in the idealized study
compared with the target, whereas the second exaggerates the effect in the actual study com-
pared with the idealized study. These biases cannot be modelled by using additive bias models,
and we assume that they reduce or increase the intervention effect multiplicatively.
Assuming multiple independent sources k=1, . . . ,KI of internal proportional bias, we write
βIik to represent the effect of an internal proportional bias source k on the estimated interven-
tion effect in study i, and similarly we write βEik to represent an external bias. In the absence
of additive biases, we would allow for a single internal proportional bias βIik by assuming the
model yi|βIik ∼ f.βIikθi, s2i /. To allow for a single external proportional bias βEik in the absence
of additive biases or unexplained between-study heterogeneity, we would assume that θi =
βEikθ.
The total internal proportional bias in study i is Πk βIik =βIi ∼f.μIiβ ,σI 2iβ /, and similarly the
total external proportional bias is Πk βEik = βEi ∼ f.μEiβ ,σE 2iβ /. Methods for eliciting the prop-
ortional biases βik and deriving μIiβ ,σ
I 2
iβ ,μ
E
iβ and σ
E 2
iβ are discussed in Section 6.2. To allow
for internal additive bias δIi as well as internal proportional bias β
I
i , we assume the model
yi ∼f.βIi θi + δi, s2i /. To allow for external additive bias δEi and proportional bias βEi , we assume
that θi =βEikθ+ δEi . A model which incorporates internal and external biases is then
yi|δIi , δEi ,βIi ,βEi ∼f{βIi .βEi θ+ δEi /+ δIi , s2i }:
We recall the distributions that were assumed earlier for the additive biases δIi ∼ f.μIiδ,σI 2iδ /
and δEi ∼f.μEiδ,σE 2iδ /, now written with a subscript δ. Using the distribution of the product of
independent variables (Armitage and Berry, 2001), we obtain
yi ∼f{μIiβ.μEiβθ+μEiδ/+μIiδ, s2i + .μI 2iβ +σI 2iβ /.θ2σE 2iβ +σE 2iδ /+σI 2iβ .θμEiβ +μEiδ/2 +σI 2iδ + τ2}
.5/
where τ2 again represents unexplained between-study heterogeneity.
When using data from a single study i and a single set of elicited distributions for the additive
and proportional biases in study i, the bias-adjusted estimate of the target intervention effect is
θˆ= .yi −μIiβμEiδ −μIiδ/=μIiβμEiβ : .6/
The formula for the corresponding standard error of θˆ is a function of the intervention effect θ,
for which we substitute the estimate θˆ:
SE.θˆ/=
(
1
μIiβμ
E
iβ
)2
{s2i + .μI 2iβ +σI 2iβ /.θˆ
2
σE 2iβ +σE 2iδ /+σI 2iβ .θˆμEiβ +μEiδ/2 +σI 2iδ }: .7/
As when adjusting for additive biases, we consider it preferable to accumulate bias distribu-
tions within assessors before pooling across assessors. The effects of additive and proportional
biases are combined during adjustment of each study’s results. To obtain pooled bias-adjusted
results for a particular study, we therefore adjust for each assessor separately as above, then
average adjusted results across assessors. A bias-adjusted meta-analysis is performed by ﬁtting
a standard random-effects model to the adjusted effect estimates and their standard errors,
again using a moment estimate for any unexplained heterogeneity τ2. Alternative approaches
are discussed as sensitivity analyses in Section 6.4.
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Fig. 7. Elicitation scale for quantifying proportional bias
6.2. Elicitation of bias distributions
The information in the completed bias checklists (Tables 1 and 2) is used to inform opinion on
the size of each proportional bias in each study.For eachbias category identiﬁed as proportional,
whether internal or external, the assessor is asked to consider the following question.
What proportional change to the intervention effect (represented by the log-relative-risk,
ignoring sampling variation) might this bias induce?
The assessor is given a copy of an elicitation scale (Fig. 7) for each bias and asked to mark the
value which they feel is most likely, together with a 67% range for the reduction or exaggeration
that is induced in the intervention effect, such that they feel that the true answer is twice as likely
to lie inside rather than outside this range. The assessor is also asked to consider whether only
exaggeration of the intervention effect is possible and reduction is impossible (or vice versa),
and if so to indicate this by marking a bound at 1. The scale that is shown is symmetric with
respect to the proportional reduction or exaggeration.
As for the additive biases, we ﬁt symmetric distributions to the logarithms of the range esti-
mates that were chosen for each proportional bias k in study i, assuming that the 67% range rep-
resents approximately λik ±ωik on the log-scale. To ﬁnd moments for total internal proportional
bias and total external proportional bias, which are products of multiple proportional biases on
the original scale, we assume log-normality (Evans et al., 1993). Total internal proportional bias
then has expectation μIiβ = exp.λIi +ωI 2i =2/ and variance σI 2iβ ={exp.ωI 2i /−1} exp.2λIi +ωI 2i /,
where λIi =ΣkλIik and ωI 2i =Σk ωI 2ik , with similar expressions for total external proportional
bias.
This approach does not acknowledge the bounds at 1 which assessors marked for some biases.
As a sensitivity analysis in Section 6.4, we ﬁt beta distributions to biases which were believed
to be bounded while continuing to assume symmetric distributions for unbounded biases. The
beta distribution is ﬁtted to the mode and outer range limit, whereas the log-normal distribu-
tion that was described above is ﬁtted to the two range limits. In future elicitations, we would
prefer the visual scale in Fig. 7 to be logarithmic (as in Fig. 2), since this scale is used in anal-
ysis.
6.3. Quantifying proportional biases in the anti-D immunoglobulin studies
Intervention bias, the external bias that is caused by differences between the study intervention
and the target intervention, is present in many of the anti-D immunoglobulin studies, and the
size of this bias is plausibly proportional to the magnitude of the treatment effect. The inter-
ventions differ from the target in up to three ways: the dose of anti-D immunoglobulin that
was used, timing of occasions given and delivery policy, which refers to the deﬁnition of the
population receiving the intervention and whether the intervention was offered or given (i.e.
those refusing not included).
In Hermann et al. (1984), the intervention differed from the target in dose and timing and in
that only women who received the intervention were included in the study (Table 4). Another
proportional bias arises in Hermann et al. (1984) as a detection bias, since Hermann et al. (1984)
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Fig. 8. Proportional biases in Hermann et al. (1984), 67% ranges of distributions elicited from four assessors
(A–D) and means and 67% ranges for total internal and external proportional bias
admitted that the cases of sensitization that were identiﬁed may have included false positive
results. False positive results in both arms cause dilution of the intervention effect, and the
resulting bias is greater when the intervention is more effective. Outcome bias arises in Her-
mann et al. (1984) through sensitization being measured at 8 months after delivery rather than
during a subsequent pregnancy (Table 4). This may cause false positive and false negative results
and may similarly be assumed proportional to the intervention effect.
Fig. 8 shows the distributions that were elicited for proportional biases in Hermann et al.
(1984) from the same four assessors, together with the resulting distributions for total inter-
nal and external proportional bias. Values below 1 represent a reduction in the magnitude of
the intervention effect, whereas values above 1 represent an exaggeration. It was clear that the
detection bias that is caused by false positive cases of sensitization would reduce the interven-
tion effect, as would giving anti-D immunoglobulin on only one rather than two occasions,
whereas the higher dose would exaggerate the effect in comparison with the target UK setting,
though the assessors’ opinions differ somewhat on the sizes of these effects and the associated
uncertainty. Opinions over the size and direction of the effects of the delivery policy and timing
of outcome measurement in Hermann et al. (1984) are varied, but the 67% ranges that were
elicited are overlapping.
The effect of adjusting the Hermann et al. (1984) study results for both proportional and
additive bias is illustrated in Fig. 5(b), for the four assessors separately and pooled. The pooled
adjusted estimate and standard error are obtained as medians of the four assessors’ adjusted
estimates and standard errors. Adjusting for proportional bias causes a noticeable widening in
the 95% CI for two of the assessors but, after pooling, the additional effect of adjusting for
proportional bias is not very great. After allowance for all biases under the assumptions of
model (5), the odds ratio is 0.37 (95% CI 0.03, 4.68). In comparison with the results that were
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adjusted for additive bias only, the estimate has moved slightly further from the null and the
interval is wider (Table 5). The corresponding effective number of events in a large study of rare
events falls by approximately a third in both arms (Table 5).
6.4. Full bias-adjusted meta-analysis
As described for the Hermann et al. (1984) study in Section 6.3, we elicited distributions for the
proportional biases in the other seven anti-D immunoglobulin studies. Under the assumptions
of model (5), we adjust the study estimates and standard errors and perform a meta-analysis
that is adjusted for all additive and proportional biases. Fig. 6(c) presents the results from this
analysis. In comparison with the results that were adjusted for additive bias only, the standard
error increases for ﬁve of eight of the studies, and the magnitude of the change in standard
error tends to be larger in these studies. Again, the most noticeable effect is seen for MacKenzie
et al. (1999), where the standard error of the intervention effect increases by a ratio of 1.74
(comparing Figs 6(b) and 6(c)). Comparing against the unadjusted results, the overall effect of
bias adjustment is highest for MacKenzie et al. (1999) and Mayne et al. (1997) (Fig. 6). We recall
that the NICE conclusions were based principally on these two studies, which were chosen on
the basis of relevance to the target UK setting (Chilcott et al., 2003).
In a meta-analysis that is adjusted for additive and proportional bias, the odds ratio of sensi-
tization is estimated as 0.25 (95% CI 0.11, 0.56). In comparison with the unadjusted results, the
estimate has shifted from the null value by just over 10%,whereas the variance has almost tripled
(Table 5). The effective number of events has fallen to 36% (treated arm) and 40% (control arm)
of the numbers that are represented by the unadjusted meta-analysis result (Table 5). However,
there remains strong evidence for the effectiveness of routine antenatal anti-D prophylaxis.
In the analysis that was adjusted for all biases, the between-study variance τ2 is again es-
timated as 0. In comparison with the unadjusted analysis, the variance of the log-odds-ratio
estimates has decreased by 61% and the typical within-study variance (Higgins and Thompson,
2002) has almost tripled. In general, we expect adjustment for internal and external biases to
remove much of the heterogeneity in a meta-analysis. If substantial heterogeneity remained, we
would suspect a problem with the process of bias adjustment or a problem with combining the
set of studies. For example, one ormore sources of biasmay not have been adequately addressed.
To investigate, one could look carefully at the outlying studies, obtain a second opinion on the
bias checklists for these and check for errors in the analysis.
To investigate the robustness of these results, we additionally perform themeta-analysis under
several variations on the assumptions that were made above. The ﬁrst of these acknowledges the
bound at 1 which assessors declared for some proportional biases. A beta distribution is ﬁtted
to the mode and outer range limit, using a binary search algorithm since the beta distribution
percentiles cannot be expressed in closed form. Distributions for total internal and external
proportional bias are then not easily derived, since they may represent products of multiple beta
and log-normal distributions, so we obtain these through forward simulation. The odds ratio
estimate and CI from this meta-analysis are identical to two decimal places to those from the
analysis ignoring the bounds.
In a second sensitivity analysis, we take a different approach to pooling across assessors.
Pooled distributions for each study are obtained for each of total internal additive bias, total
external additive bias, total internal proportional bias and total external proportional bias,
based on medians of the four assessors’ means and standard deviations. The observed results
from each study are adjusted for the pooled bias distributions by using equations (6) and (7), and
then a standard random-effects meta-analysis is performed. This analysis gives an odds ratio of
0.26 (95% CI 0.11, 0.58), which is very close to the initial analysis. As a third variation on the
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Fig. 9. Meta-analysis of anti-D immunoglobulin studies adjusted for additive and proportional biases, using
the elicited opinions of assessors (a) A, (b) B, (c) C and (d) D separately (with 95% CIs)
analysis that was described in Section 6.1, we adjust the study-speciﬁc standard errors by using
an estimate for θˆ which is common across studies, for each assessor separately. Estimation of a
common θˆ is achieved by taking an iterative approach to ﬁtting a random-effects meta-analysis
model, where the study variances are functions of θˆ. In this analysis, the odds ratio is estimated
as 0.24 (95% CI 0.10, 0.54), which is again very close to the initial results.
Finally, we perform four separate bias-adjusted meta-analyses by using the elicited bias dis-
tributions that were given by each assessor (Fig. 9). The bias-adjusted odds ratio is estimated
as 0.26 (0.12, 0.60), 0.25 (0.11, 0.58), 0.26 (0.11, 0.59) and 0.31 (0.14, 0.70), when using the
opinions that were elicited from assessors A, B, C and D respectively. The difference in results
between assessor D and assessors A–C are largely caused by differing opinions over the biases in
Tovey et al. (1983). In a bias-adjusted meta-analysis of the other seven anti-D immunoglobulin
studies, the results that were based on each single assessor’s opinions on biases are very similar
across assessors. In all these sensitivity analyses, the between-study variance τ2 was estimated
as 0.
In the anti-D immunoglobulin example, the bias-adjusted results seem robust to different
methods of pooling across assessors and are little affected by whether the bounds are acknowl-
edged when ﬁtting distributions to proportional biases. The sensitivity analyses increase our
conﬁdence in the results that were obtained from the initial bias-adjusted meta-analysis. Pro-
grams for implementing the bias adjustmentmethods can be obtained by contacting the authors.
7. Incorporating empirical evidence on bias
Our method of bias adjustment requires distributions to be speciﬁed for each category of bias
in every study. Currently, we have based all distributions on elicited opinion alone, but it would
be desirable for the bias distributions to be informed by empirical evidence wherever possible.
Empirical evidence on bias can be obtained from meta-epidemiological studies, which pool data
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from a collection of meta-analyses to study the effects of particular study characteristics. Many
meta-epidemiological studies have investigated the effects of selection bias on the magnitude
of treatment effect, through comparing randomized and non-randomized studies (Deeks et al.,
2003), or looking at the effect of inadequate allocation concealment and inadequate allocation
sequence generation (Schulz et al., 1995; Moher et al., 1998; Kjaergard et al., 2001; Juni et al.,
2001; Balk et al., 2002). Some of the latter studies have also examined the effect on treatment
effect of a double-blind study design and of reported attrition. Analysis of meta-epidemiologi-
cal data sets could inform the assessors’ opinions during the elicitation process or could supply
empirical distributions to be used directly for particular biases. To take either approach would
require measures of between-study variation in bias, but the meta-epidemiological studies that
have been carried out to date have only reported estimates and CIs for the average effects of bias.
A model for extracting empirical information on bias from a meta-epidemiological data set
has been proposed recently (Welton et al., 2008; Sterne et al., 2008). This was exempliﬁed in
assessing the bias due to inadequate allocation concealment by using the data thatwere obtained
by Schulz et al. (1995). The model that was constructed for the observed data distinguishes three
components of variability in bias: uncertainty in mean bias; between-study (within-meta-anal-
ysis) variability in bias; between-meta-analysis variability in bias. In our elicitation approach to
obtaining distributions for bias, we elicit the combined variance for each bias, which is the sum
of these components. Elicitation alone could not provide estimates for these separate compo-
nents of bias uncertainty. Welton et al. (2008) used the empirical evidence on bias to provide
prior distributions for a model which combines results from studies of low and high quality (i.e.
with inadequate and adequate allocation concealment). The new meta-analysis was assumed
exchangeable with previous meta-analyses and the studies included were not assessed in detail.
Under this model, the variance for a low quality study includes the estimated variance for
mean bias and the between-meta-analysis variance in bias, which cannot be compensated for
by increasing the number of low quality studies. If relying on generic meta-epidemiological data
alone, a set of biased studies thus has a limit to the precision for estimating the target effect. In
our approach, we gain information by assessing the biases in our particular studies rather than
assuming exchangeability with previous meta-analyses.
Our objective in modelling biases is to make adjustment for all sources of internal and exter-
nal bias. In this context, it would be extremely rare to be able to base all bias distributions on
empirical evidence alone. Where there are external biases, these are speciﬁc to the differences
between the source study and target question, and meta-epidemiological studies are unlikely
to provide relevant information. For certain internal biases, empirical information from meta-
epidemiological studies could inform the elicitation, and assessors could modify the generic
bias distributions according to the severity of bias in each study.
8. Discussion
In this paper, we propose methods for adjusting for the varying rigour and relevance of studies
that are included in a typical evidence synthesis. We have presented a strategy for identifying
internal and external biases, tools for eliciting quantitative distributions for the biases and sim-
ple models for adjustment. Our objective is to describe an approach allowing decisions to be
based on all available evidence, with less rigorous or less relevant studies discounted by using
computationally simple methods.
Our aim was to ﬁnd an approach that can be implemented in a routine analysis setting and
this governed our choice of methods. A method-of-moments estimate was used for the ex-
cess heterogeneity τ2, though it may in principle be preferable to use an iterative method of
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estimation (DerSimonian and Kacker, 2007). Alternatively, the models could be ﬁtted within
a full Bayesian framework, making proper allowance for the uncertainty in τ2 and the study
sampling variances s2i (Smith et al., 1995). A full Bayesian analysis could also incorporate biases
that are elicited through a ﬂexible elicitation procedure (Oakley and O’Hagan, 2007). For sim-
plicity, we have assumed log-normality throughout; we checked the results against those from
ﬁtting beta distributions to the proportional biases and found no difference in our example.
When pooling elicited distributions acrossmultiple assessors, we take averages of the adjusted
estimates and their standard errors, to construct the opinion of a ‘typical’ assessor (among
those included). We chose this approach in preference to the linear opinion pool or the loga-
rithmic opinion pool, where the pooled opinion from multiple assessors represents weakened
or strengthened knowledge respectively compared with a single assessor (O’Hagan et al., 2006).
In our approach, central rather than extreme opinions dominate the analysis. In cases of gen-
uinely divergent opinions between assessors, we would consider it better to acknowledge this
elsewhere, through discussion and presentation of bias-adjustedmeta-analyses for each assessor
separately, rather than to combine the opinions statistically.
It was necessary to choose a set of bias categories which may be assumed independent, since
correlations between biases would be difﬁcult to elicit and empirical evidence is unlikely to be
available. The assumption is perhaps least comfortable when considering the category ‘other
bias suspected’, which may be correlated with other categories of internal bias. The correla-
tion could be positive if considerable deﬁciencies in a study lead us to suspect additional biases
which are less easily detected from the publication, or it could be negative if so many biases
are apparent that we believe that there is little scope for additional bias. Another example in
the anti-D immunoglobulin studies is the external biases of dose and timing, which would have
been better considered as a single bias rather than as two supposedly independent biases. By
failing to acknowledge a positive correlation between two biases, we would underestimate the
total bias-adjusted variance (or would overestimate it if failing to acknowledge a negative cor-
relation). Individual biases are likely to be positively correlated across trials. Since we do not
take this into account, we expect our degree of variance adjustment to be conservative, meaning
that the study results should be downweighted further.
The decision to assume a direct form for the biases affecting the intervention effect was
based on the view that constructing separate models for every bias would be unrealistic in most
practical settings. We also chose to model biases as either additive or proportional, as a simpliﬁ-
cation which we expect to be adequate in many circumstances. Within our approach, it would be
possible to incorporate more complex forms of adjustment for certain biases, by adjusting for
these before the other biases. In observational studies, it may be desirable to use a detailedmodel
of adjustment for uncontrolled confounding (Greenland, 2003; Schneeweiss et al., 2005), par-
ticularly where studies are reported in more detail than in the anti-D immunoglobulin example.
In randomized trials, we may wish to adjust carefully for the bias due to attrition, by including
prior beliefs about informative missingness (White et al., 2008).
Our chosen elicitation process was a compromise between group and individual elicitation,
and this worked well from a practical point of view. It would be preferable for the team of bias
assessors to include researchers from several different disciplines, as are routinely found in a
team carrying out an evidence synthesis. We suggest that it is sufﬁcient to elicit opinions from
four or ﬁve assessors. Although larger numbers could improve generalizability, it is important
that the individuals who are selected are knowledgeable and sufﬁciently motivated to take part
in what may be a time-consuming and somewhat challenging process. In our experience, for
each study, the bias elicitation process required an hour, plus at least an hour’s preparation,
and completion of the bias checklist (by one individual only) required at least three hours.
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If carrying out analyses to inform politically sensitive decisions concerning availability of par-
ticular treatments, it would be important for stakeholders to approve the set of bias assessors
in advance. Completed bias checklists and summaries of bias distributions that were elicited for
each included study could subsequently be made publicly available. In the event of conﬂict over
the bias-adjusted results, stakeholders could look for cases of disagreement between assessors
and undertake sensitivity analyses accordingly by using software made publicly available on the
Web. This process would promote transparency in the synthesis of available evidence.
The quantiﬁcation of biases by assessors on elicitation scales would beneﬁt enormously from
the availability of interactive elicitation software, as recommended by O’Hagan et al. (2006).
This would provide the opportunity for assessors to see the distributions ﬁtted to their ranges
and to modify them if they do not adequately reﬂect their beliefs, and to be alerted to any likely
errors or inconsistencies in the ranges that are chosen. For example, assessors could be shown
their chosen distribution with tertiles marked, to check that they believe the three resulting
intervals to be equally probable. Similarly, it would be useful to mark extreme percentiles of
the distribution. Ideally, the software would allow users to adjust the central 67% range limits,
and simultaneously to update the implied distribution. Interactive software would also offer a
means of showing assessors relevant empirical evidence when available.
If the aim of a meta-analysis is to summarize the literature rather than to address a target
question, there is no need to adjust for external biases since differences between the (idealized)
studies are accepted as diversity. The need to adjust for internal biases remains and our method
can be applied directly to these.
In the anti-D immunoglobulin example, it was previously unclear how to make best use of
the information that is available from studies which showed clear evidence of internal bias and
which varied in relevance to the target UK setting. Our bias-adjusted meta-analysis was carried
out to exemplify the methods rather than as a deﬁnitive analysis of these data. It would be pref-
erable to involve assessors from several disciplines at the elicitation stage rather than only two
(biostatistics and obstetric medicine), including at least one assessor with specialist knowledge
of transfusion medicine. We place least conﬁdence in our assessments of the external biases due
to differences in dose and frequency of anti-D immunoglobulin.
Our methods for bias adjustment are presented in the context of a two-arm comparison of a
binary outcome, but they could be modiﬁed for other settings. Other types of outcome could be
addressed by adapting the elicitation scales and questions. For a non-comparative target setting,
such as estimation of a prevalence, changes to the bias checklists would also be required.
When deciding how to handle biases in evidence synthesis, researchers should consider
whether their aim is to answer a speciﬁc target question by using the evidence which is cur-
rently available, or to summarize the literature. Our methods have been developed with the
ﬁrst of these aims in mind. When a decision must be taken on the basis of the evidence that
is available, it is essential to exploit fully the information in the studies and, for this, detailed
bias assessment and elicitation are worthwhile. The element of judgement could be considered
controversial, but we feel that even stronger judgements are always made, when eliminating
evidence on somewhat arbitrary grounds and treating the evidence included as ‘perfect’. Our
approach makes judgements explicit, transparent and open to sensitivity analysis. This can only
increase the accountability of decisions that are made by organizations such as the NICE.
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